Stem Cells and Diabetes Archives
PharmaFrontiers Announces New Stem Cell Technologies For Diabetes and Multiple Scelorosis Therapies
PharmaFrontiers Corp. (OTCBB:PFTR), has announced they will present new information regarding their adult human T-cell vaccination and stem cell regenerative medicine technologies. The presentaitons will be held at the 2006 Annual Meeting of the International Society for Cellular Therapy (ISCT) in Berlin at the proArte Hotel on May 5, 2006.
One of the key presentations will focus on the latest data regarding Pharmafrontier's proprietary T-cell vaccination technology treating multiple sclerosis. The presentation will demonstrate the use of attenuated autologous autoreactive T-cells for vaccinations in T-cell mediated autoimmunity.
...Posted on March 28, 2006 05:49 PM | Comments (0)
Stem Cell Diabetes Therapy Has Mixed Results
Researchers at the University of Chicago are working to confirm results of a previous study that has brought some hope to researchers and diabetic patients worldwide. However, in the case of the U. of Chicago tests, the results were seen as mixed.
The researchers were could in fact reverse type-1 diabetes in one-third of mice used in the study. However, they were unable to find insulin-producing beta cells derived from donated spleen cells.
...Continue reading "Stem Cell Diabetes Therapy Has Mixed Results"
Posted on March 27, 2006 12:33 PM | Comments (0)
Ups and Downs Regarding Other Cellular Transplant Therapies
This is certainly off topic for us here, but since we have seen some news leaking out regarding this, I thought it may be of interest to those of us that watch cellular biology and related fields.
It appears that some diabetics are visting a clinic in Mexico injections of pig cells, with the hope that this xenotransplant may cure them of diabetes.
Naturally, there is quite a list of experts that are worried about the risks involved to the patients that are being dubbed as xenotourists, and to their own community around them.
...Continue reading "Ups and Downs Regarding Other Cellular Transplant Therapies"
Posted on March 10, 2006 06:41 PM | Comments (0)
MultiCell Technologies Announced 10-KSB Filing and Science Advancements
MultiCell Technologies, Inc. (OTCBB:MCET), therapeutics developer for the treating of degenerative neurological diseases, metabolic and endocrinological disorders, and infectious diseases, hosted a conference call with a simultaneous webcast on Wednesday, March 8, discussing its 10-KSB filing and strategic initiatives to develop a broad portfolio of novel medical therapies and stem cell technologies.
Now that said, as we have been leaning more and more to the guts of developments .. lets get to the science of this press release ..
-- MultiCell is utilizing its proprietary technology platforms to discover and develop therapeutics targeting degenerative neurological diseases, including multiple sclerosis, metabolic and endocrinological disorders, including Type-1 diabetes, infectious diseases, including hepatitis, sepsis and influenza, and degenerative ocular diseases, including macular degeneration.
...Continue reading "MultiCell Technologies Announced 10-KSB Filing and Science Advancements"
Posted on March 10, 2006 06:30 PM | Comments (0)
Adult Stem Cells Possible Solution for Diabetes
Been a while since we have dug into stem cells and diabetes related research. Seems suitable then to find this latest article discussing adult stem cells in the pancreas that can be transformed into insulin-producing cells.
Researchers at the Burnham Institute for Medical Research and the Rebecca and John Moores Cancer Center at the University of California at San Diego have discovered that endocrine progenitor stem cells in the adult human pancreas may be key to developing new treatments for diabetes.
...Continue reading "Adult Stem Cells Possible Solution for Diabetes"
Posted on February 21, 2006 04:10 PM | Comments (0)
Mesoblast and Cordis Corporation to Join Forces in Adult Stem Cell Heart Trial
Melbourne, Australia; 7 November 2005: Australian adult stem cell company, Mesoblast Limited (ASX:MSB), today announced that Cordis Corporation, a Johnson & Johnson company, will join forces in its upcoming adult stem cell Pilot Cardiac Clinical Trial through an agreement with Mesoblast’s American affiliated company, Angioblast Systems Inc.
...Continue reading "Mesoblast and Cordis Corporation to Join Forces in Adult Stem Cell Heart Trial"
Posted on December 2, 2005 09:30 PM | Comments (0)
Plureon Corporation Announces Diabetes Research and Development Agreement With BD
WINSTON-SALEM, N.C., Oct. 14 - Plureon Corporation ("Plureon") today announced that it has entered into an agreement with BD (Becton, Dickinson and Company) in the field of diabetes research and development using Plureon's platform stem cell technology. Plureon's stem cells may be obtained from placental tissues that are usually discarded as medical waste after birth.
Under the agreement, BD will sponsor Plureon's research efforts for up to three years and will be responsible for further development of the technology. Plureon retains rights to provide future manufacturing and medical education support to BD.
...Continue reading "Plureon Corporation Announces Diabetes Research and Development Agreement With BD"
Posted on November 3, 2005 02:02 PM | Comments (0)
Study: Well-Known Protein Helps Stem Cells Become Secretory Cells
Johns Hopkins researchers have discovered that a single protein regulates secretion levels in the fruit fly’s salivary gland and its skin-like outer layer.
Described in the May 15 issue of Development, the finding improves understanding of how cells become specialized for secretion, which is a critical ability of certain glands and cell types in organisms from insects to humans.
The researchers discovered that a protein called CrebA single-handedly controls the entire set of events leading to secretion in the fruit fly’s salivary gland and epidermis, its skin-like outer layer.
...Continue reading "Study: Well-Known Protein Helps Stem Cells Become Secretory Cells"
Posted on July 27, 2005 01:34 PM | Comments (0)
Stem Cells Could Treat Diabetes If Coaxed Onto That Path
As many of you already know, diabetes is one of the most targetted uses for stem cell research. Fortunately, many corporate and university level research teams are making some progress in getting stem cells to differentiate into pacreatic cells or beta cells, replacing the faulty cells that are no longer producing insulin.
"We think that ultimately the way to cure people with diabetes, or at least many patients with diabetes, is to replace those cells," said Michael German of the University of California-San Francisco's Diabetes Center.
Currently clinics worldwide have been working on some forms of treatment, including the University of California - San Francisco, where they transplant beta cells from cadavers into diabetes patients.
...Continue reading "Stem Cells Could Treat Diabetes If Coaxed Onto That Path"
Posted on July 21, 2005 04:54 PM | Comments (0)
Korea Again Makes Stem Cell Therapy Breakthrough
Researchers in Korea have taken another leap forward advancing technologies revolving around the growth of stem cells into specific cells.
This latest breakthrough was headed by Seoul National University professor Moon Shin-yong, and his team. They said yesterday that they have found a method of coaxing human embryonic stem cells into insulin-secreting cells, essentially one step before making the beta cells that are in the pancreas.
...Continue reading "Korea Again Makes Stem Cell Therapy Breakthrough"
Posted on June 29, 2005 03:28 PM | Comments (0)
American Diabetes Association Urges Fast Senate Action on Stem Cell Research Legislation
ALEXANDRIA, Va., June 28 -- The American Diabetes Association (the Association) today urged the U.S. Senate to take up and pass the "Stem Cell Research Enhancement Act of 2005" (S.471), legislation that would accelerate stem cell research by easing existing restrictions and supporting research that uses embryonic stem cells. In May, the U.S. House of Representatives passed the stem cell legislation with clear, bipartisan support, and public opinion polls show a strong majority of Americans support stem cell research. The Association has been a strong supporter of the Stem Cell Research Enhancement Act because it would advance the search for better treatment and a cure for diabetes, one of the nation's most prevalent, debilitating and deadly diseases.
...Posted on June 29, 2005 10:29 AM | Comments (0)
Singapore Pursuing Biotechnology
Singapore is pushing to be seen as a biotechnology center for world-class research and development where laboratory findings are rapidly converted into working clinical applications.
"We are seeing more companies with a strong interest to locate their R&D facilities in Singapore in order to leverage on Singapore’s capabilities in biomedical sciences research," said Mr Yeoh Keat Chuan, who is the Deputy Director of Biomedical Sciences Group part of the Singapore Economic Development Board. "Three of the world’s leading pharmaceutical companies, Eli Lilly, GlaxoSmithKline and Novartis have established corporate R&D centres in Singapore, alongside numerous other biotechnology companies."
...Continue reading "Singapore Pursuing Biotechnology"
Posted on June 27, 2005 12:26 PM | Comments (0)
AmCyte to Present at BIO 2005 Conference
Los Angeles – June 8th, 2005. AmCyte Inc., a leader in encapsulated islet replacement and pancreatic adult stem cells, will present at the BIO 2005 Conference in Philadelphia on Tuesday June 21st at 12 noon in Room A as part of the Business Forum.
AmCyte is proud to be selected to present at the largest biotechnology conference of the year with well over 10,000 delegates expected representing every biotechnology and pharmaceutical region of the world.
...Continue reading "AmCyte to Present at BIO 2005 Conference"
Posted on June 20, 2005 07:13 PM | Comments (0)
Hwang Woo-Suk Participate in Cloning Research With Harvard Team
In Korea, well known Seoul National University professor and stem cell researcher Hwang Woo-suk is planing to start a stem cell research project focusing on diabetes with a Harvard University team.
"After concluding a contract in July or August, the Harvard University team will invite us this autumn. We look to study diabetes and other diseases together," the 52-year-old said.
The Harvard team is likely to be led by Dr. Douglas Melton, a father of two children with diabetes, who has been working on finding a cure to the confounding disease.
...Continue reading "Hwang Woo-Suk Participate in Cloning Research With Harvard Team"
Posted on June 3, 2005 08:27 PM | Comments (0)
Cloned Embryos Created to Match Stem Cells, Patients
South Korean scientists have announced a highly efficient way to clone human cells. This latest discovery could alter the scientific and political debate over the procedure.
Effectively they have created 11 new lines of cloned human embryonic stem cells. For the first time, this includes two that are genetically matched to patients with a disease. The two disease-carrying cell lines were cloned from patients with juvenile diabetes and an inherited blood disorder.
...Continue reading "Cloned Embryos Created to Match Stem Cells, Patients"
Posted on May 20, 2005 01:13 PM | Comments (0)
Precise timing enabled pig-to-rat transplants to cure diabetes
May 16, 2005 — Scientists at Washington University School of Medicine in St. Louis have learned that a temporal "window of opportunity" was critical to their earlier successes in treating diabetic rats with embryonic pig tissues.
In those experiments, published in 2004, researchers were surprised to find that they didn't have to give anti-rejection drugs to diabetic rats treated with embryonic pig cell transplants. They had expected rats that received no immune suppression would reject the transplants. Instead, the new tissues engrafted with little difficulty, curing the rats of their diabetes....
...Continue reading "Precise timing enabled pig-to-rat transplants to cure diabetes"
Posted on May 16, 2005 11:57 PM | Comments (0)
Vitro Files New Patent for Stem Cell Therapy of Diabetes
AURORA, Colo.--(BUSINESS WIRE)--April 26, 2005--Vitro Diagnostics, Inc. (OTCBB: VODG), a biotechnology company, announced the filing of a new patent application with the United States Patent and Trademark Office regarding a procedure for the generation of beta islets from stem cells. The Company discovered a new process to generate immortal cell lines that can be induced to form cells of the beta islets by exposure to certain environmental conditions. The new patent application describes a method of producing and maintaining beta islet progenitor cells as well as about 30 new human beta islet progenitor cell lines. The new cell lines developed by the Company are not derived from human embryonic stem cells but rather from partially differentiated human pancreatic cell lines previously developed by the Company.
Continue reading "Vitro Files New Patent for Stem Cell Therapy of Diabetes"
Posted on May 3, 2005 12:53 PM | Comments (0)
More On Brain Stem Cells As Possible Cure For Diabetes
Wired has a good followup article regarding the current research being done at Stanford University regarding neurons from fetal brains that are coaxed into to become cells that produce insulin.
Granted this is more or less the same information we discussed before, but its a bit more detailed in this article. If you are looking for information regarding stem cell research and diabetes, like this is a good resource for solutions on the horizon.
However, the one issue that likely will be seen as contentious is that Seung Kim who authored the paper on this research, indicates that the insulin-producing cells are derived from embryonic stem cells.....
...Continue reading "More On Brain Stem Cells As Possible Cure For Diabetes"
Posted on April 27, 2005 03:16 PM | Comments (0)
Stem Cells From The Brain To Possibly Cure Diabetes
The BBC has a good article on how scientists in the US are looking at a possible method of curing diabetes using stem cells from the brain.
Though the work is obviously no ready for human testing, the results coming from animal studies have shown to be very promising.
Researchers at Stanford University have found a way to coax the immature brain cells to fully develop into insulin producing islet cells that are lacking in diabetes.....
...Continue reading "Stem Cells From The Brain To Possibly Cure Diabetes"
Posted on April 26, 2005 06:15 PM | Comments (0)
Islet Cell Implant From Mother Cures Diatebetes In Woman
This is a bit off topic, but as we know in the focus of stem cell research, this kind of news will be affected .. hopefully in the near term. Slashdot is discussing an announcment from Kyoto, Japan, where a Japanese woman has been seemingly been cured of diabetes via a donor transplant of insulin-producing cells from her mother.
Now these are not stem cells, these are directly her mother's islet cells. Additionally, this is one of the first times an islet cell transplant from a living donor has actually worked.....
Continue reading "Islet Cell Implant From Mother Cures Diatebetes In Woman"
Posted on April 20, 2005 12:12 PM | Comments (0)
Additional Stem Cell Articles In This Category
* Scientists Share Type 1 Diabetes Research* White Blood Cells Tweaked to Produce Insulin
* Scaffolding Allows Stem Cells To Become Functional Fat Cells
* Son's Disease Motivates Stem Cell Pioneer
* Genzyme and Viacell Team Up To Conquer Diabetes
* First North American Encapsulated Islet Transplant without Long-t
* Diabetes Related Stem Cell Study Indicates Could Contribute To Cu
* Vitro Diagnostics Quarterlies and Announces New Stem Cell Lines f
* Diabetes: Is Regeneration of Pancreatic [Beta] Cells Possible?
* Argentina: More on Fernandez Vina's Work On Diabetes
* Spleen May Be Source Of Stem Cells For Diabetes Treatment
* Stem Cell Research Progress Regarding Diabetes
* Stem Cell Treatment Reverses Diabetes
* Illinois House Republican Leader Tom Cross Promotes Embryonic Ste